Myokardia, inc. (MYOK)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Dec'14
Assets
Current assets
Cash and cash equivalents

131,204

101,436

235,159

443,693

466,254

246,122

335,279

346,827

183,865

224,571

227,184

117,305

135,594

135,797

77,120

87,615

99,495

112,265

64,545

43,648

Short-term investments

218,809

314,691

181,932

114,792

92,540

68,564

43,845

51,766

39,822

31,933

19,993

16,011

12,039

4,072

-

-

-

-

-

-

Receivable from collaboration partner

-

-

-

-

-

-

2,565

-

-

1,013

-

-

-

45,000

-

-

-

-

-

-

Prepaid expenses and other current assets

7,486

7,709

7,598

4,316

4,312

4,760

2,566

2,604

2,320

1,876

1,545

1,242

1,813

1,394

762

1,066

1,245

1,282

622

430

Total current assets

357,499

423,836

424,689

562,801

563,106

319,446

384,255

401,197

226,007

259,393

248,722

134,558

149,446

186,263

77,882

88,681

100,740

113,547

65,167

44,078

Property and equipment, net

19,801

15,743

7,148

5,435

5,592

5,138

4,905

4,883

4,030

3,147

2,633

2,856

2,604

2,758

2,729

2,930

3,007

2,744

2,893

2,423

Operating lease right-of-use assets

51,981

417

1,028

1,756

2,473

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term investments

10,077

14,153

63,328

43,952

69,524

80,148

32,506

27,648

35,621

19,900

36,003

31,986

31,978

12,002

-

-

-

-

-

-

Restricted cash and other

1,968

1,945

2,404

2,109

2,611

2,521

2,312

426

514

368

432

363

388

283

750

289

289

289

2,003

388

Total assets

441,326

456,094

498,597

616,053

643,306

407,253

423,978

434,154

266,172

282,808

287,790

169,763

184,416

201,306

81,361

91,900

104,036

116,580

70,063

46,889

Liabilities and stockholders’ equity
Current liabilities
Accounts payable

5,573

6,237

6,528

3,037

5,194

2,946

2,454

2,766

2,292

2,301

2,030

1,362

2,366

1,798

1,731

1,672

1,994

2,143

1,685

886

Accrued liabilities

32,236

41,292

36,507

24,744

20,469

20,758

18,790

13,553

10,628

11,639

10,634

10,153

7,064

8,690

6,930

5,500

4,827

5,633

4,018

2,331

Prepayment from collaboration partner

-

-

-

2,256

3,099

12,973

10,943

9,115

7,701

4,432

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities - current

7,851

383

1,050

1,831

2,529

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

12,400

21,588

28,227

33,558

22,500

22,500

22,500

22,500

3,550

7,099

10,649

14,199

14,199

14,199

Redeemable convertible preferred stock call option liability, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

314

Total current liabilities

45,660

47,912

44,085

31,868

31,291

36,677

44,587

47,022

48,848

51,930

35,164

34,015

31,930

32,988

12,211

14,271

17,470

21,975

19,902

17,730

Operating lease liability

44,658

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term liabilities

1,908

1,908

2,159

-

73

9

54

99

151

202

246

303

364

436

503

573

658

732

781

278

Deferred revenue - noncurrent

-

-

-

-

-

-

-

-

-

-

5,625

11,250

16,875

22,500

-

-

-

-

3,550

14,199

Total liabilities

92,226

49,820

46,244

31,868

31,364

36,686

44,641

47,121

48,999

52,132

41,035

45,568

49,169

55,924

12,714

14,844

18,128

22,707

24,233

32,207

Commitments and contingencies (Note 7)

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

Stockholders’ equity
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding

0

0

0

0

-

0

0

0

0

-

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value, 150,000,000 shares authorized at March 31, 2020 and December 31, 2019; 46,612,186 and 46,379,073 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

5

5

5

5

5

4

4

4

4

4

4

3

3

3

3

3

3

3

-

-

Additional paid-in capital

897,058

884,486

871,894

861,880

851,664

573,183

566,432

558,376

370,173

365,719

363,205

226,471

224,683

223,208

160,740

159,918

159,010

158,555

-

-

Accumulated other comprehensive income

671

549

453

497

296

-67

-222

-259

-329

-192

-52

-50

-47

8

-

-

-

-

-

-

Accumulated deficit

-548,600

-478,766

-420,000

-278,200

-240,023

-202,553

-186,877

-171,088

-152,675

-134,855

-116,402

-102,229

-89,392

-77,837

-92,096

-82,865

-73,105

-64,685

-56,213

-36,906

Total stockholders’ equity

349,100

406,274

452,353

584,185

611,942

370,567

379,337

387,033

217,173

230,676

246,755

124,195

135,247

145,382

68,647

77,056

85,908

93,873

-56,213

-36,906

Total liabilities and stockholders’ equity

441,326

456,094

498,597

616,053

643,306

407,253

423,978

434,154

266,172

282,808

287,790

169,763

184,416

201,306

81,361

91,900

104,036

116,580

70,063

46,889